HI
Hims & Hers Health
HIMS · NYSE
$27.92 -0.89% (-$0.25)
1M -7.67%
Market Cap $6.23B
P/E Ratio -
Div. Yield -
ROE 30.03%
Bulios Fair Price
$37.45
34.1% upside
Current Price
$27.92
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HIMS is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
12 /100
Expensive P/B 19.22x
P/FCF 69.29x
PEG 26.28x
Growth
100 /100
Growing Book val. growth 20.17%
Rev. growth 64.55%
FCF growth N/A
Profitability
28 /100
Weak Net margin 5.51%
Op. margin 3.59%
FCF margin 3.49%
Quality
9 /100
Poor ROE 30.03%
ROA 3.91%
Asset turnover 0.71x
Debt
11 /100
High Current ratio 0.93x
Debt/Equity 4.77x
Net debt/EBITDA N/A
Stability
36 /100
Moderate Rev. volatility 5.22%
EPS volatility 319.95%
Profitable years 2
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HIMS
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Andrew Dudum
Employees
2,442
Headquarters
San Francisco
Upcoming events
09 NOV
Earnings
Upcoming earnings report